{"id":147252,"date":"2017-06-26T13:46:51","date_gmt":"2017-06-26T18:46:51","guid":{"rendered":"https:\/\/centralhealth.sbdev.io\/?p=147252"},"modified":"2017-07-26T13:47:08","modified_gmt":"2017-07-26T18:47:08","slug":"collaboration-aimed-long-term-alzheimers-genetics-biomarkers-study","status":"publish","type":"post","link":"https:\/\/www.centralhealth.net\/es\/collaboration-aimed-long-term-alzheimers-genetics-biomarkers-study\/","title":{"rendered":"Colaboraci\u00f3n para el estudio a largo plazo de la gen\u00e9tica y los biomarcadores del Alzheimer"},"content":{"rendered":"<p>Imagine poder hacerse un an\u00e1lisis de sangre que detecte sus riesgos de desarrollar Alzheimer y, a continuaci\u00f3n, recibir una pastilla para evitar que la enfermedad se apodere de su cerebro. Una colaboraci\u00f3n entre Seton y la Dell Medical School de la Universidad de Texas en Austin pretende hacer realidad esa visi\u00f3n alg\u00fan d\u00eda.<\/p>\n<p>Seton y Dell Med han recibido una subvenci\u00f3n de cinco a\u00f1os del Texas Council on Alzheimer's Disease and Related Disorders para participar en un programa de investigaci\u00f3n multisitio, denominado Texas Alzheimer's Research and Care Consortium (TARCC).<\/p>\n<p>El primer a\u00f1o de la subvenci\u00f3n concede a Seton y Dell Med $800.000 para inscribir a 100 participantes como parte del estudio observacional longitudinal. Los participantes se someter\u00e1n a pruebas de memoria y de sangre. Los investigadores utilizar\u00e1n los resultados para analizar el ADN de los participantes y detectar posibles biomarcadores que puedan estar relacionados con la demencia.<\/p>","protected":false},"excerpt":{"rendered":"<p>Imagine being able to take a blood test that detects your risks of developing Alzheimer\u2019s, and then getting a pill to prevent the disease from ever taking hold of your [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":147253,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","footnotes":""},"categories":[4],"tags":[],"class_list":["post-147252","post","type-post","status-publish","format-standard","has-post-thumbnail","category-news","entry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.centralhealth.net\/es\/wp-json\/wp\/v2\/posts\/147252","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.centralhealth.net\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.centralhealth.net\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.centralhealth.net\/es\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.centralhealth.net\/es\/wp-json\/wp\/v2\/comments?post=147252"}],"version-history":[{"count":0,"href":"https:\/\/www.centralhealth.net\/es\/wp-json\/wp\/v2\/posts\/147252\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.centralhealth.net\/es\/wp-json\/wp\/v2\/media\/147253"}],"wp:attachment":[{"href":"https:\/\/www.centralhealth.net\/es\/wp-json\/wp\/v2\/media?parent=147252"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.centralhealth.net\/es\/wp-json\/wp\/v2\/categories?post=147252"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.centralhealth.net\/es\/wp-json\/wp\/v2\/tags?post=147252"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}